Associated Papers
Postoperative Circulating Tumor DNA Can Predict High Risk Patients with Colorectal Cancer Based on Next-Generation Sequencing.
Lee CS et al.
Cancers, 2021
34439344 (PubMed )
Supplement: cancers-13-04190-s001.zip › cancers-1321037-supplementary.pdf
Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor Therapy.
Yamamoto T et al.
Cancers, 2020
32708005 (PubMed )
Supplement: cancers-12-02010-s001.pdf
Select a paper to view details